Pancreatic Cancer Research

ResearcherUniversity of LjubljanaActive in the last 2 years

Miha Petrič

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1002-4853; OpenAlex author ID A5108850417. Sources: ClinicalTrials.gov.

Their work

Papers
2
Trials
1
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2020: 1 trial · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 2

  1. Intraoperative electrochemotherapy of the posterior resection surface after pancreaticoduodenectomy: Preliminary results of a hybrid approach treatment of panc… Co-author DOI 10.1016/j.bioelechem.2023.108576↗
  2. Plasma Extracellular Vesicle Characteristics Correlate with Tumor Differentiation and Predict Overall Survival in Patients with Pancreatic Ductal Adenocarcinom… Co-author DOI 10.3390/jpm11020077↗

Trials 1

  1. Electrochemotherapy of Posterior Resection Surface for Lowering Disease Recurrence Rate in Pancreatic Cancer (PanECT Study) Study chair NCT04281290↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Maša Bošnjak · 1 shared paper, 1 shared trial, 2020–2024 · strength 0.41
  2. Blaž Trotovšek · 1 shared paper, 1 shared trial, 2020–2024 · strength 0.41
  3. Maja Čemažar · 1 shared paper, 1 shared trial, 2020–2024 · strength 0.41
  4. Mihajlo Djokić · 1 shared paper, 1 shared trial, 2020–2024 · strength 0.41
  5. Gregor Serša · 1 shared paper, 1 shared trial, 2020–2024 · strength 0.41
  6. Žan Čebron · 1 shared paper, 1 shared trial, 2020–2024 · strength 0.41
  7. Bostjan Markelc · 1 shared trial, 2020 · strength 0.17
  8. David Badovinac · 1 shared trial, 2020 · strength 0.17
  9. Aleš Tomažič · 1 shared paper, 2021 · strength 0.13
  10. David Badovinac · 1 shared paper, 2021 · strength 0.13
  11. Metka Lenassi · 1 shared paper, 2021 · strength 0.13
  12. Hana Zavrtanik Čarni · 1 shared paper, 2021 · strength 0.13
  13. Vita Dolžan · 1 shared paper, 2021 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.